Case ReportImmunomodulatory Therapy in Multiple Sclerosis and Breast Cancer Risk: A Case Report and Literature Review
References (33)
The epidemiology of multiple sclerosis
Neurol Clin
(1996)- et al.
Glatiramer acetate: mechanisms of action in multiple sclerosis
Autoimmun Rev
(2007) - et al.
CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis
Clin Immunol
(2007) Management of worsening multiple sclerosis with mitoxantrone: a review
Clin Ther
(2006)- et al.
Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis
Arch Neurol
(1983) - et al.
Altered antibody pattern to Epstein-Barr virus but not other herpes viruses in multiple sclerosis: a population based case-control study from western Norway
J Neurol Neurosurg Psych
(1998) - et al.
The implications of Epstein-Barr virus in multiple sclerosis-a review
Acta Neurol Scand Suppl
(1997) - et al.
Regulatory T cells in immunologic self-tolerance and autoimmune disease
Int Rev Immunol
(2005) - et al.
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
J Exp Med
(2004)
Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II
J Exp Med
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy
J Exp Med
Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes
Diabetes
Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial
Neurology
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group
Ann Neurol
Randomized double-blind placebo controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis
Lancet
Cited by (7)
HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer
2014, Journal of the Neurological SciencesCitation Excerpt :Methotrexate administration in psoriasis patients has been previously associated only with B-cell derived LPD's [69]. Immunomodulating agents do not seem to correlate adequately with risk for cancer formation [70], although Glatiramer Acetate induced breast cancer is a possibility that deserves further investigation [71]. Moreover, a primary CNS lymphoma emergence in a patient under treatment with Natalizumab has raised questions for a possible causative role [72].
Increased breast cancer risk for patients with multiple sclerosis: A nationwide population-based cohort study
2014, European Journal of NeurologyAssessment of cancer risk with β-interferon treatment for multiple sclerosis
2014, Journal of Neurology, Neurosurgery and PsychiatryMeningioma after immunomodulation for multiple sclerosis
2012, Arquivos de Neuro-Psiquiatria
Electronic forwarding or copying is a violation of US and International Copyright Laws.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by CIG Media Group, LP, ISSN #1526-8209, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.